Tech Company Financing Transactions

Solace Pharmaceuticals Funding Round

On 5/1/2007, Solace Pharmaceuticals raised $15 million in Series A financing from InterWest Partners, Polaris Partners and PureTech Ventures.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

Four Cambridge Center 2nd floor
Cambridge, MA 02142
USA

Phone

(617) 482-2333

Website

www.solacepharma.com

Email Address

[email protected]

Overview

Solace was co-founded in March 2006 by PureTech Ventures and a preeminent team of scientific, clinical, regulatory and drug development experts who are collaborating to translate groundbreaking scientific discoveries in pain biology into innovative, effective therapeutic strategies for addressing chronic pain.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eliot Forster

        

Vice President

Alasdair Naylor

        

Browse more venture capital transactions:

Prev: 5/1/2007: Channel M venture capital transaction
Next: 5/1/2007: Secure64 Software venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary